Kistler-Tiffany Companies’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,864
Closed -$2K 707
2020
Q4
$2K Hold
2,864
﹤0.01% 603
2020
Q3
$6K Buy
+2,864
New +$8.18K ﹤0.01% 534

Other funds holding BMY.RT

Kistler-Tiffany Companies's BMY.RT Position: Q1 2021 in Review

Kistler-Tiffany Companies sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 2,864 shares — an estimated $2K sold.

Kistler-Tiffany Companies first reported a position in BMY.RT in Q3 2020 and held it in 2 quarters. The position peaked at $6K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Kistler-Tiffany Companies reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 2,864 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $2K.
  • Kistler-Tiffany Companies first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q3 2020 and held it in 2 quarters.
  • Kistler-Tiffany Companies's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $6K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Kistler-Tiffany Companies's 13F filing for Q1 2021, filed 7 May 2021.